Same Indication

Imatinib vs Irbesartan

Imatinib vs Irbesartan: Overview

This comparison examines the pharmacological differences between Imatinib and Irbesartan.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Irbesartan — 11-15 hours.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O; Irbesartan — C25H28N6O.

Molecular Weight: Imatinib — 493.6030 g/mol; Irbesartan — 428.5320 g/mol.

Type: Imatinib — Small molecule; Irbesartan — Small molecule.